CA Stock MarketDetailed Quotes
NARA PanGenomic Health Inc
- 0.100
- 0.0000.00%
15min DelayMarket Closed Jun 25 13:14 ET
1.05MMarket Cap-114P/E (TTM)
0.000High0.000Low408Volume0.080Open0.100Pre Close0.00Turnover0.50052wk High0.00%Turnover Ratio10.50MShares0.05052wk Low-0.871EPS TTM1.05MFloat Cap3.650Historical HighLossP/E (Static)10.50MShs Float0.050Historical Low-1.271EPS LYR0.00%Amplitude--Dividend TTM-0.57P/B1Lot Size--Div YieldTTM
PanGenomic Health Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -62.69%374.14K | 12.52%908.96K | 28.23%1.05M | 319.25%3.64M | 68.06%1.01M | 715.71%1M | 744.53%807.8K | 821.88K | 868.66K | 600.63K |
| Selling and administrative expenses | -59.06%350.14K | 30.95%800.61K | 26.38%825.9K | 322.34%3.03M | 98.46%911.54K | 607.62%855.25K | 579.13%611.4K | --653.51K | --717.84K | --459.31K |
| -Selling and marketing expense | -88.99%18.06K | -81.82%12.23K | -65.82%45.57K | 507.28%495.69K | 60.44%130.96K | --164.13K | --67.3K | --133.31K | --81.63K | --81.63K |
| -General and administrative expense | -51.95%332.08K | 44.90%788.38K | 50.01%780.33K | 298.61%2.54M | 106.67%780.58K | 471.82%691.12K | 504.38%544.1K | --520.2K | --636.21K | --377.69K |
| Research and development costs | -101.39%-1.65K | -66.14%64.87K | 0.27%159.98K | 311.90%534.11K | -50.35%64.39K | --118.58K | --191.59K | --159.55K | --129.67K | --129.67K |
| Depreciation amortization depletion | 7.94%3.13K | 14.93%3.13K | 19.64%3.02K | 422.47%11.11K | 39.63%2.97K | --2.9K | --2.72K | --2.53K | --2.13K | --2.13K |
| -Depreciation and amortization | 7.94%3.13K | 14.93%3.13K | 19.64%3.02K | 422.47%11.11K | 39.63%2.97K | --2.9K | --2.72K | --2.53K | --2.13K | --2.13K |
| Other operating expenses | -13.41%22.52K | 1,828.97%40.35K | 933.10%64.98K | 241.22%64.91K | 220.54%30.52K | 1,159.10%26.01K | -62.81%2.09K | --6.29K | --19.02K | --9.52K |
| Operating profit | 62.69%-374.14K | -12.52%-908.96K | -28.23%-1.05M | -319.25%-3.64M | -68.06%-1.01M | -715.71%-1M | -744.53%-807.8K | -821.88K | -868.66K | -600.63K |
| Net non-operating interest income (expenses) | -7,829.33%-11.59K | -1,210.92%-8.95K | -520.29%-2.3K | -91.45%1.14K | -110.50%-360 | -97.85%150 | -75.38%806 | 547 | 13.38K | 3.43K |
| Non-operating interest income | 17.46%565 | -31.51%552 | -17.03%687 | -84.51%2.45K | -83.57%563 | -93.11%481 | -76.65%806 | --828 | --15.84K | --3.43K |
| Non-operating interest expense | 3,573.41%12.16K | --9.51K | 962.63%2.99K | -46.84%1.31K | --923 | --331 | ---- | --281 | --2.47K | --0 |
| Other net income (expenses) | -788.48%-14.64K | -5,354.76%-43.53K | -2.03K | -365.63%-8.35M | -8.35M | 2.13K | -798 | -1.79M | ||
| Gain on sale of security | -390.60%-6.18K | -814.91%-7.3K | ---2.03K | --7.47K | --6.14K | --2.13K | ---798 | ---- | ---- | ---- |
| Special income (charges) | ---8.46K | ---36.23K | ---- | -366.05%-8.36M | ---8.36M | --0 | --0 | ---- | ---1.79M | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 366.05%8.36M | ---- | ---- | ---- | ---- | --1.79M | ---- |
| -Less:Write off | --8.46K | --36.23K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Income before tax | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -762.87%-1M | -774.45%-807.79K | -821.33K | -2.65M | -2.39M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -762.87%-1M | -774.45%-807.79K | -821.33K | -2.65M | -2.39M |
| Net income continuous operations | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -762.87%-1M | -774.45%-807.79K | ---821.33K | ---2.65M | ---2.39M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -762.87%-1M | -774.45%-807.79K | -821.33K | -2.65M | -2.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 59.98%-400.38K | -19.02%-961.44K | -28.84%-1.06M | -352.73%-11.99M | -291.63%-9.36M | -762.87%-1M | -774.45%-807.79K | -821.33K | -2.65M | -2.39M |
| Diluted earnings per share | 79.85%-0.0403 | 42.29%-0.1 | 52.21%-0.1 | -87.30%-1.2709 | -62.88%-0.9923 | -577.05%-0.2 | -636.26%-0.1733 | -0.2093 | -0.6786 | -0.6092 |
| Basic earnings per share | 79.85%-0.0403 | 42.29%-0.1 | 52.21%-0.1 | -87.30%-1.2709 | -62.88%-0.9923 | -577.05%-0.2 | -636.26%-0.1733 | -0.2093 | -0.6786 | -0.6092 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg